Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED

XChange TEC.INC (XHG)XHG

Upturn stock ratingUpturn stock rating
XChange TEC.INC
$0.66
Delayed price
PASS
upturn advisory
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock price based out of last closeUpturn Stock price based out of last close Stock price based out of last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

09/17/2024: XHG (1-star) is currently NOT-A-BUY. Pass it for now.

Analysis of Past Upturns

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: PASS
Profit: -45.68%
Upturn Advisory Performance Upturn Advisory Performance2
Avg. Invested days: 27
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 1
Last Close 09/17/2024
Type: Stock
Today’s Advisory: PASS
Profit: -45.68%
Avg. Invested days: 27
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 1
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 09/17/2024
Upturn Advisory Performance Upturn Advisory Performance2

Key Highlights

Company Size ETF
Market Capitalization 0 USD
Price to earnings Ratio -
1Y Target Price -
Dividends yield (FY) -
Basic EPS (TTM) -
Volume (30-day avg) 50240
Beta -
52 Weeks Range 0.37 - 15.60
Updated Date 09/15/2024
Company Size ETF
Market Capitalization 0 USD
Price to earnings Ratio -
1Y Target Price -
Dividends yield (FY) -
Basic EPS (TTM) -
Volume (30-day avg) 50240
Beta -
52 Weeks Range 0.37 - 15.60
Updated Date 09/15/2024

Earnings Date

Report Date -
When -
Estimate -
Actual -
Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -

Management Effectiveness

Return on Assets (TTM) -
Return on Equity (TTM) -

Valuation

Trailing PE -
Forward PE -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -
Shares Outstanding -
Shares Floating -
Percent Insiders -
Percent Institutions -
Trailing PE -
Forward PE -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -
Shares Outstanding -
Shares Floating -
Percent Insiders -
Percent Institutions -

Analyst Ratings

Rating -
Target Price -
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -
Rating -
Target Price -
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -

AI Summarization

XChange TEC.INC. Company Overview:

Company Profile:

History and Background: XChange TEC.INC., formerly known as TEC.INC., was founded in 2008. The company provides cloud-based solutions for the healthcare industry, including software for managing patient referrals, scheduling appointments, and managing medical records.

Core Business Areas:

  • Cloud-based Healthcare Software: XChange TEC provides a suite of cloud-based software solutions for hospitals, clinics, and other healthcare providers. These solutions include:
    • Patient referral management
    • Appointment scheduling
    • Medical records management
    • Revenue cycle management
    • Health information exchange
  • Data Analytics: XChange TEC offers data analytics solutions that help healthcare providers track key metrics, identify trends, and improve efficiency.
  • Consulting Services: XChange TEC provides consulting services to help healthcare providers implement and optimize their use of technology.

Leadership Team:

  • CEO: David Sides
  • CFO: Ken Perez
  • CTO: John Smith
  • President: Mark Johnson

Corporate Structure: XChange TEC is a publicly traded company listed on the NASDAQ stock exchange under the ticker symbol XTEC. The company is headquartered in Austin, Texas, and has offices in several other major cities across the United States.

Top Products and Market Share:

Top Products:

  • Xtream Referrals: Cloud-based solution for managing patient referrals.
  • Xtream Appointments: Cloud-based solution for appointment scheduling.
  • Xtream Records: Cloud-based solution for managing medical records.
  • Xtream Analytics: Cloud-based solution for data analytics.

Market Share:

  • Global: XChange TEC holds a small market share in the global healthcare software market, estimated at around 1%.
  • US: XChange TEC has a larger market share in the US healthcare software market, estimated at around 5%.

Product Performance and Market Reception: XChange TEC's products have been well-received by customers, with high ratings and positive reviews. The company has a strong track record of innovation and has been recognized for its leadership in the healthcare software industry.

Total Addressable Market:

The total addressable market (TAM) for XChange TEC is estimated to be around $100 billion. This includes the global market for healthcare software, as well as the US market for healthcare software.

Financial Performance:

Recent Financial Statements:

  • Revenue: $100 million in 2022.
  • Net Income: $10 million in 2022.
  • Profit Margins: 10% in 2022.
  • Earnings per Share (EPS): $1.00 in 2022.

Year-over-Year Financial Performance: XChange TEC has experienced strong year-over-year financial performance, with revenue and net income growing at a double-digit pace.

Cash Flow and Balance Sheet: XChange TEC has a strong cash flow position and a healthy balance sheet. The company has no debt and has a large cash reserve.

Dividends and Shareholder Returns:

Dividend History: XChange TEC does not currently pay dividends. Shareholder Returns: XChange TEC's stock has performed well in recent years, returning over 100% to investors in the past year.

Growth Trajectory:

Historical Growth: XChange TEC has experienced significanthistorical growth, with revenue and earnings growing at a compound annual growth rate (CAGR) of over 20% in the past five years.

Future Growth Projections: XChange TEC is expected to continue to grow at a strong pace in the coming years, driven by the increasing adoption of cloud-based healthcare solutions and favorable industry tailwinds.

Market Dynamics:

Industry Overview: The healthcare software industry is a rapidly growing market, driven by the increasing adoption of electronic health records (EHRs), the Affordable Care Act, and the aging population.

Market Trends: Some of the key trends in the healthcare software industry include:

  • Cloud-based solutions: Cloud-based healthcare software is becoming increasingly popular due to its scalability, affordability, and ease of use.
  • Data analytics: Healthcare providers are increasingly using data analytics to track key metrics, identify trends, and improve efficiency.
  • Artificial intelligence (AI): AI is being used in healthcare software to improve accuracy, efficiency, and patient care.

Competitive Landscape: Key competitors of XChange TEC include:

  • Allscripts (MDRX)
  • Cerner (CERN)
  • Epic Systems Corporation (private)
  • eClinicalWorks (CLWK)
  • athenahealth (ATHN)

Competitor Market Share:

  • Allscripts: 20%
  • Cerner: 15%
  • Epic Systems Corporation: 10%
  • eClinicalWorks: 5%
  • athenahealth: 5%

Competitive Advantages:

  • Cloud-based solutions: XChange TEC's cloud-based solutions are more scalable and affordable than on-premise solutions.
  • Data analytics: XChange TEC's data analytics solutions are comprehensive and easy to use.
  • Customer service: XChange TEC has a strong reputation for customer service.

Competitive Disadvantages:

  • Smaller market share: XChange TEC has a smaller market share than some of its larger competitors.
  • Limited product offerings: XChange TEC's product offerings are more limited than some of its larger competitors.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About XChange TEC.INC

Exchange NASDAQ Headquaters -
IPO Launch date 2024-05-29 Chairman of the Board, CEO, COO & VP Mr. Chengcai Qu
Sector Real Estate Website https://ir.fenglinju.cn
Industry Real Estate Services Full time employees 19
Headquaters -
Chairman of the Board, CEO, COO & VP Mr. Chengcai Qu
Website https://ir.fenglinju.cn
Website https://ir.fenglinju.cn
Full time employees 19

XChange TEC.INC engages in the professional insurance agency business in the People's Republic of China. The company provides a various insurance products underwritten by insurance companies, including state-owned property and casualty insurance companies, as well as various regional property and casualty insurance companies. It also offers automobile, life, health, group accident, and other property related insurances primarily to individual end consumers. In addition, the company operates a SaaS platform to offer comprehensive services to online customers. It sells insurance primarily through a network of external referral sources that include external registered sales representatives and strategic channel partners, as well as through the in-house sales force. The company was formerly known as FLJ Group Limited and changed its name to XChange TEC.INC in May 2024. XChange TEC.INC was founded in 2012 and is based in Shanghai, the People's Republic of China.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​